Dermira, Inc.
(NASDAQ : DERM)

( )
DERM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
IMMUImmunomedics, Inc. -0.32%85.2511.0%$715.31m
MRNAModerna, Inc. -0.04%70.520.0%$666.35m
AMGNAmgen, Inc. 0.51%248.301.3%$659.17m
ILMNIllumina, Inc. 0.01%305.503.5%$626.58m
NVAXNovavax, Inc. -2.91%107.9596.5%$605.28m
GILDGilead Sciences, Inc. -1.19%62.101.0%$578.27m
REGNRegeneron Pharmaceuticals, Inc. 0.30%573.612.7%$438.99m
BIIBBiogen, Inc. 0.11%282.351.6%$350.80m
VRTXVertex Pharmaceuticals, Inc. 0.96%270.311.9%$346.01m
SRNESorrento Therapeutics, Inc. 14.29%11.601.5%$320.77m
ALXNAlexion Pharmaceuticals, Inc. -0.74%112.462.0%$279.94m
EXASEXACT Sciences Corp. 2.32%102.0120.7%$271.56m
SGENSeattle Genetics, Inc. 0.24%190.966.0%$227.45m
VXRTVaxart, Inc. -2.50%6.830.0%$197.82m
MNTAMomenta Pharmaceuticals, Inc. 0.06%52.493.0%$177.06m

Company Profile

Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients. Dermira’s portfolio of five product candidates targets significant market opportunities. It was founded in 2010 and headquartered in Menlo Park, California.